BCDA - BioCardia Inc. (BCDA) Q4 2023 Earnings Call Transcript
2024-03-27 20:00:12 ET
BioCardia, Inc. (BCDA)
Q4 2023 Results Conference Call
March 27, 2024 04:30 PM ET
Company Participants
Miranda Peto - Investor Relations
Peter Altman - President and Chief Executive Officer
David McClung - Chief Financial Officer
Presentation
Operator
Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to the BioCardia 2023 Year-End Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode. [Operator Instructions]. Participants on this call are advised that the audio of this conference call is being broadcast live over the Internet and is also being recorded for playback purposes. A webcast replay of the call will be available approximately one hour after the end of the call.
I would now like to turn the call over to Miranda Peto, BioCardia Investor Relations. Please go ahead, Miranda.
Miranda Peto
Thank you, Rocco. Good afternoon and thank you for participating in today's conference call. Joining me from BioCardia's leadership team are Peter Altman, PhD, President and Chief Executive Officer and David McClung, the company's Chief Financial Officer. During this call, management will be making forward-looking statements, including statements that address BioCardia's expectations for future performance and operational results, references to management's intentions, beliefs, projections, outlook, analyses and current expectations.
Such factors include, among others, the inherent uncertainties associated with developing new products, technologies and obtaining regulatory approvals. Forward-looking statements involve risks and other factors that may cause actual results to differ materially from those statements. For more information about these risks, please refer to the risk factors and cautionary statements described in BioCardia's report on Form 10-K filed with the SEC this morning....
BioCardia, Inc. (BCDA) Q4 2023 Earnings Call Transcript